Spotlight — November Issue of The Self-Insurer: CAR-T Therapies and Employer Strategies

Exploring the Evolving Role of CAR-T Therapies for Self-Insured Employers

For those who want to stay ahead in the world of cell and gene therapies, the November issue of The Self-Insurer is a must-read. This edition provides a comprehensive overview of CAR-T therapies, including:

• How these innovative treatments are expanding into earlier care settings.
• What the new indications mean for self-insured plan sponsors.
• Why proactive benefit strategies are more important than ever.

This article helps employers understand how these therapies may affect benefit design.

Access the Article: Read the full November issue of The Self-Insurer here.

If you have questions or would like to discuss the implications of these developments for your organization, please contact us to arrange a conversation.